VRDN fundamentals
Viridian Therapeutics, Inc. earnings per share and revenue
VRDN earnings per share for the last quarter are -0.81 USD whereas the estimation was -1.04 USD which accounts for 21.76% surprise. Company revenue for the same period amounts to 72.00 k USD despite the estimated figure of 44.00 k USD. Estimated earnings per share for the next quarter are -0.97 USD, and revenue is expected to reach 55.08 k USD. Also watch annual changes over time to get a bigger picture of VRDN earnings per share and revenue dynamics.
Next report date
≈
Report periodQ1 2025
EPS estimate−0.97USD
Revenue estimate55.08 KUSD
EPS
Forecast
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
−1.80
−1.35
−0.90
−0.45
0.00
Reported
Estimate
Currency: USD
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
−1.61
−1.27
−1.09
−1.35
−0.79
−1.02
−1.15
−0.81
—
—
—
—
Estimate
−1.01
−1.26
−1.25
−0.98
−1.09
−0.87
−1.06
−1.04
−0.97
−0.99
−1.02
−1.05
Surprise
−59.31%
−0.74%
+12.48%
−38.06%
+27.46%
−17.14%
−8.77%
+21.76%
—
—
—
—
Revenue
Forecast
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
0.00
70.00 K
140.00 K
210.00 K
280.00 K
Reported
Estimate
Currency: USD
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
98.00 K
72.00 K
72.00 K
72.00 K
72.00 K
72.00 K
86.00 K
72.00 K
—
—
—
—
Estimate
116.78 K
254.00 K
145.25 K
154.18 K
88.10 K
78.15 K
84.92 K
44.00 K
55.08 K
55.08 K
55.08 K
55.17 K
Surprise
−16.08%
−71.65%
−50.43%
−53.30%
−18.27%
−7.87%
+1.28%
+63.64%
—
—
—
—